Loading insider details...
Latest Form 4 (Feb 20, 2026): Grant/Award of 35,000 TRVI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Dec 3, 2025 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 4,225 | $2.2K |
| Jun 3, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 8,550 | n/a |
| Mar 12, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 4,560 | n/a |
| Feb 20, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 41,000 | n/a |
| Dec 17, 2024 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 15,000 | $7.7K |
| Feb 16, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 28,500 | n/a |
| Feb 16, 2023 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 40,000 | n/a |
| Feb 15, 2022 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Apr 15, 2021 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 25,000 | n/a |